Evidence map›Paper›PMID 35549985›Full record

ArticleBioengineered2022

CircRNA protein tyrosine phosphatase receptor type a suppresses proliferation and induces apoptosis of lung adenocarcinoma cells via regulation of microRNA-582-3p.

Jixin Jiang, Hui Ge, Jie Yang, Yunfei Qiao, Xingxiang Xu, Yanming Geng

RetractedOpen access · goldAbstract readRetracted Publication
In one paragraph

Article in Bioengineered, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jixin JiangDepartment of Pathology, Northern Jiangsu People's Hospital, Yangzhou University/Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, China.
Hui GeDepartment of Respiratory and Critical Care Medicine, Northern Jiangsu People's Hospital, Yangzhou University/Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, China.
Jie YangDepartment of Respiratory and Critical Care Medicine, Northern Jiangsu People's Hospital, Yangzhou University/Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, China.
Yunfei QiaoDepartment of Respiratory and Critical Care Medicine, Northern Jiangsu People's Hospital, Yangzhou University/Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, China.
Xingxiang XuDepartment of Respiratory and Critical Care Medicine, Northern Jiangsu People's Hospital, Yangzhou University/Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, China.
Yanming GengDepartment of Respiratory and Critical Care Medicine, Northern Jiangsu People's Hospital, Yangzhou University/Clinical Medical College, Yangzhou University, Yangzhou, Jiangsu, China.
Yangzhou University · CNNorthern Jiangsu People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circular RNAs (circRNAs) are associated with cancer progression. The present study aimed to examine the function of circRNA protein tyrosine phosphatase receptor type A (circRNA_PTPRA) in lung cancer cells and elucidate the underlying molecular mechanisms. The levels of circRNA_PTPRA and microRNA (miRNA/miR)-582-3p were measured in lung cancer tissue and cells using reverse transcription-quantitative polymerase chain reaction (RT-qPCR). Cell proliferation and apoptosis were evaluated using an 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and flow cytometry, respectively. The expression of cyclin D1, caspase-3, and cleaved caspase-3 was assessed via western blotting. The sites of circRNA_PTPRA/miR-582-3p interaction were identified using StarBase, and validated using a dual-luciferase reporter assay. We observed that circRNA_PTPRA levels were remarkably decreased, and miR-582-3p expression was up-regulated in lung cancer tissues and cells. circRNA_PTPRA directly interacts with miR-582-3p and downregulates miR-582-3p expression in lung cancer cells. Moreover, an miR-582-3p inhibitor decreased lung cancer cell proliferation and promoted apoptosis. The overexpression of circRNA_PTPRA decreased cell proliferation and increased apoptotic cell numbers, whereas miR-582-3p overexpression reversed these effects. These findings demonstrate that the up-regulation of circRNA_PTPRA significantly reduces lung cancer cell proliferation and induces apoptosis by regulating miR-582-3p expression.

Indexed as

Adenocarcinoma of LungLung NeoplasmsMicroRNAsApoptosisCaspase 3Cell ProliferationHumansProtein Tyrosine PhosphatasesRNA, CircularCaspase 3MicroRNAsMIRN582 microRNA, humanProtein Tyrosine PhosphatasesRNA, Circularapoptosiscircular RNA protein tyrosine phosphatase receptor type ALung adenocarcinomamicroRNA-582-3pproliferation

Identifiers

PMID35549985
PMCPMC9276004
OpenAlexW4280514841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.